News
Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside Chardan initiates Bright Minds with a Buy rating, citing over $1 billion ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
Find the latest Bright Minds Biosciences Inc. (DRUG) stock quote, history, news and other vital information to help you with your stock trading and investing.
Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) Return DRUG S&P/TSX Composite index (^GSPTSE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results